![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram](https://www.researchgate.net/publication/232766331/figure/fig2/AS:667591068631043@1536177522180/GOLD-2011-pharmacologic-management-of-COPD-based-on-combined-assessment-of-airflow.png)
GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram
![Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram](https://www.researchgate.net/publication/336127873/figure/fig1/AS:816932626386944@1571783324021/Management-of-stable-COPD-SABA-short-acting-bronchodilator-agonist-LAMA-long-acting.png)
Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram
![Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram](https://www.researchgate.net/publication/49628996/figure/fig1/AS:305844810993666@1449930493787/Algorithm-showing-use-of-inhaled-therapies-FEV-1-forced-expiratory-volume-in-1-s-ICS.png)
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
![Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a9e459777276a68e48f8c76f19425bdaae7a6e07/1-Table3-1.png)
Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar
![Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends | Journal of Medicinal Chemistry Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm5013227/asset/images/large/jm-2014-013227_0019.jpeg)
Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends | Journal of Medicinal Chemistry
![Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV) Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)](https://pbs.twimg.com/media/ESSKIW8U4AA4Yv5.jpg)